IL-6 detection in multiple sclerosis brain

[1]  C. Raine,et al.  The adhesion molecule and cytokine profile of multiple sclerosis lesions , 1995, Annals of neurology.

[2]  T. Ohtsuki,et al.  Hypoxia/reoxygenation-mediated induction of astrocyte interleukin 6: a paracrine mechanism potentially enhancing neuron survival , 1994, The Journal of experimental medicine.

[3]  Moses Rodriguez,et al.  Recombinant human IL-6 suppresses demyelination in a viral model of multiple sclerosis. , 1994, Journal of immunology.

[4]  Y. Itoyama,et al.  Expression of cytokines in brain lesions in subacute sclerosing panencephalitis , 1994, Neurology.

[5]  M. Cuzner,et al.  Cytokine mRNA expression in inflammatory multiple sclerosis lesions: detection by non-radioactive in situ hybridization. , 1993, Cytokine.

[6]  F. Aloisi,et al.  Norepinephrine and vasoactive intestinal peptide induce IL-6 secretion by astrocytes: Synergism with IL-1β and TNFα , 1993, Journal of Neuroimmunology.

[7]  E. Benveniste,et al.  Interleukin-6 production by astrocytes: Induction by the neurotransmitter norepinephrine , 1993, Journal of Neuroimmunology.

[8]  B. Barres,et al.  Multiple extracellular signals are required for long-term oligodendrocyte survival. , 1993, Development.

[9]  H. Moser,et al.  The Inflammatory Myelinopathy of Adreno‐Leukodystrophy: Cells, Effector Molecules, and Pathogenetic Implications , 1992, Journal of neuropathology and experimental neurology.

[10]  A. Carè,et al.  Production of hemolymphopoietic cytokines (IL-6, IL-8, colony-stimulating factors) by normal human astrocytes in response to IL-1 beta and tumor necrosis factor-alpha. , 1992, Journal of immunology.

[11]  J. Vilček,et al.  Cytokine regulation of interleukin-6 gene expression in astrocytes involves activation of an NF-κ B-like nuclear protein , 1992, Journal of Neuroimmunology.

[12]  H. Ikeda,et al.  Tumour necrosis factor causes an increase in axonal transport of protein and demyelination in the mouse optic nerve , 1992, Journal of the Neurological Sciences.

[13]  C. Brosnan,et al.  Cytokine cytotoxicity against oligodendrocytes. Apoptosis induced by lymphotoxin. , 1991, Journal of immunology.

[14]  A. Reder,et al.  Cytokine levels in the cerebrospinal fluid and serum of patients with multiple sclerosis , 1991, Journal of Neuroimmunology.

[15]  C. Brosnan,et al.  Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. , 1991, The Journal of clinical investigation.

[16]  J. Merrill,et al.  Lymphokines and immunoregulatory molecules in subacute sclerosing panencephalitis. , 1991, Clinical immunology and immunopathology.

[17]  K. Frei,et al.  Production of hemopoietic colony-stimulating factors by astrocytes. , 1990, Journal of immunology.

[18]  E. Benveniste,et al.  Tumor necrosis factor-alpha production by astrocytes. Induction by lipopolysaccharide, IFN-gamma, and IL-1 beta. , 1990, Journal of immunology.

[19]  A. Billiau,et al.  Interleukin 6 production in the central nervous system during experimental autoimmune encephalomyelitis , 1990, European journal of immunology.

[20]  J. Vilček,et al.  IL-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cultured human monocytes, U937 cells, and in mice. , 1989, Journal of immunology.

[21]  J. Merrill,et al.  Tumor necrosis factor identified in multiple sclerosis brain , 1989, The Journal of experimental medicine.

[22]  M. Shin,et al.  Production of tumor necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccharide or a neurotropic virus. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[23]  R. Zinkernagel,et al.  On the cellular source and function of interleukin 6 produced in the central nervous system in viral diseases , 1989, European journal of immunology.

[24]  P. Lebon,et al.  Multiple sclerosis: Involvement of interferons in lesion pathogenesis , 1988, Annals of neurology.

[25]  K. Selmaj,et al.  Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro , 1988, Annals of neurology.

[26]  M. Shin,et al.  Production of cytotoxic factor for oligodendrocytes by stimulated astrocytes. , 1987, Journal of immunology.

[27]  J. Merrill,et al.  Immunoregulatory molecules and IL 2 receptors identified in multiple sclerosis brain. , 1986, Journal of immunology.

[28]  E. Reinherz,et al.  Multiple sclerosis Distribution of T cells, T cell subsets and Ia-positive macrophages in lesions of different ages , 1983, Journal of Neuroimmunology.

[29]  J. Prineas,et al.  Multiple sclerosis: Capping of surface immunoglobulin G on macrophages engaged in myelin breakdown , 1981, Annals of neurology.

[30]  H. Tilg,et al.  Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55. , 1994, Blood.

[31]  S. Akira,et al.  Interleukin-6 in biology and medicine. , 1993, Advances in immunology.

[32]  E. Cho,et al.  Interaction of astrocytes and newly formed oligodendrocytes in resolving multiple sclerosis lesions. , 1990, Laboratory investigation; a journal of technical methods and pathology.

[33]  C. Dinarello,et al.  Correlations and interactions in the production of interleukin-6 (IL-6), IL-1, and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF. , 1990, Blood.